- Home
- ICCC vs GEG Comparison
ICCC vs GEG Comparison
Compare ICCC & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- GEG
- Stock Information
- Founded
- ICCC 1982
- GEG 1994
- Country
- ICCC United States
- GEG United States
- Employees
- ICCC N/A
- GEG N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- ICCC Health Care
- GEG Technology
- Exchange
- ICCC Nasdaq
- GEG Nasdaq
- Market Cap
- ICCC 48.3M
- GEG 54.7M
- IPO Year
- ICCC 1987
- GEG N/A
- Fundamental
- Price
- ICCC $5.07
- GEG $1.90
- Analyst Decision
- ICCC
- GEG
- Analyst Count
- ICCC 0
- GEG 0
- Target Price
- ICCC N/A
- GEG N/A
- AVG Volume (30 Days)
- ICCC 27.6K
- GEG 7.1K
- Earning Date
- ICCC 05-14-2025
- GEG 05-07-2025
- Dividend Yield
- ICCC N/A
- GEG N/A
- EPS Growth
- ICCC N/A
- GEG N/A
- EPS
- ICCC N/A
- GEG N/A
- Revenue
- ICCC $26,493,169.00
- GEG $19,626,000.00
- Revenue This Year
- ICCC N/A
- GEG N/A
- Revenue Next Year
- ICCC N/A
- GEG N/A
- P/E Ratio
- ICCC N/A
- GEG N/A
- Revenue Growth
- ICCC 51.63
- GEG 64.34
- 52 Week Low
- ICCC $3.34
- GEG $1.70
- 52 Week High
- ICCC $5.82
- GEG $2.04
- Technical
- Relative Strength Index (RSI)
- ICCC 42.10
- GEG 48.45
- Support Level
- ICCC $5.01
- GEG $1.76
- Resistance Level
- ICCC $5.72
- GEG $1.98
- Average True Range (ATR)
- ICCC 0.18
- GEG 0.03
- MACD
- ICCC -0.05
- GEG -0.00
- Stochastic Oscillator
- ICCC 14.96
- GEG 20.00
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.